CN1137899C - 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 - Google Patents
17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 Download PDFInfo
- Publication number
- CN1137899C CN1137899C CNB001149296A CN00114929A CN1137899C CN 1137899 C CN1137899 C CN 1137899C CN B001149296 A CNB001149296 A CN B001149296A CN 00114929 A CN00114929 A CN 00114929A CN 1137899 C CN1137899 C CN 1137899C
- Authority
- CN
- China
- Prior art keywords
- compound
- diene
- ketone
- reaction
- epoxy steroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Steroid Compounds (AREA)
Abstract
Description
吸收波数cm-1 | 吸收峰强度 | 基团和振动类型 |
1300、1195 | 强 | 磺酸酯-SO2-OR伸缩振动 |
1460 | 强 | CH(CH3CH2)剪式振动 |
1626、1600 | 弱 | 苯 骨架振动 |
1664 | 强 | 烯酮 伸缩振动 |
1719 | 强 | 酮 伸缩振动 |
1117 | 强 | 醚 伸缩振动 |
805 | 强 | 环醚 骨架振动 |
3213 | 强 | 水 |
化合物 | Maximum | Minimum | 吸收带归属 | ||
λnm | ε | λnm | ε | 251nm为α、β不饱和共轭酮及α-羧基呋喃,228nm为取代苯基 | |
分析样品 | 251 | 11153 | 228 | 9171 |
δ(ppm) | 0.78(3H,d.J=6.8>Hz) | 16α-CH3 |
0.83(3H,S) | 18-CH3 | |
1.37(3H,S) | 19-CH3 | |
2.43(3H,d,J=8.24Hz) | 苯环上CH3 | |
6.11(1H,S) | C-4-H | |
6.13(1H,d,J=5.22Hz) | C-2-H | |
4.77(1H,d,J=15.9)和4.91(1H,d,J=15.7) | C-21-H |
δ(ppm) | C-1 C-2 C-3 C-4 C-5 16α-CH3 C-17152 124 185 127 157 16 9518-CH3 19-CH3 C-20 C-2117 24 196 72 |
δ(ppm) | 羧基 C-2′ C-3′ C-4′ C-5′21 142 127 130 132 |
δ(ppm) | CH3 C-1″ C-2″和C-6″165 145 120C-3″和C-5″C-4″112 148 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001149296A CN1137899C (zh) | 2000-03-16 | 2000-03-16 | 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001149296A CN1137899C (zh) | 2000-03-16 | 2000-03-16 | 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1314416A CN1314416A (zh) | 2001-09-26 |
CN1137899C true CN1137899C (zh) | 2004-02-11 |
Family
ID=4584404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001149296A Expired - Fee Related CN1137899C (zh) | 2000-03-16 | 2000-03-16 | 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1137899C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107266518A (zh) * | 2016-04-08 | 2017-10-20 | 天津金耀集团有限公司 | 一种糠酸莫米松新晶型及其制备方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007001811A (es) | 2004-08-13 | 2007-03-26 | Schering Plough Ltd | Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticoesteroide. |
CN105481933B (zh) * | 2015-12-25 | 2017-09-19 | 山东京卫制药有限公司 | 一种合成糠酸莫米松的方法 |
CN105566437B (zh) * | 2015-12-30 | 2018-07-20 | 山东京卫制药有限公司 | 一种8dm衍生物及利用其合成糠酸莫米松的方法 |
CN107266519B (zh) * | 2016-04-08 | 2021-06-29 | 天津金耀集团有限公司 | 一种9β,11β-环氧-17α-羟基-16α-甲基-21-氯代-1,4孕甾二烯-3,20-二酮新晶型及其制备方法 |
-
2000
- 2000-03-16 CN CNB001149296A patent/CN1137899C/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107266518A (zh) * | 2016-04-08 | 2017-10-20 | 天津金耀集团有限公司 | 一种糠酸莫米松新晶型及其制备方法 |
CN107266518B (zh) * | 2016-04-08 | 2021-03-30 | 天津金耀集团有限公司 | 一种糠酸莫米松晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1314416A (zh) | 2001-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69023947T2 (de) | Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus. | |
TOHMA et al. | Synthesis of the 1β-hydroxylated bile acids, unusual bile acids in human biological fluids | |
KOBAYASHI et al. | Studies on organic fluorine compounds. XXXIX. Studies on steroids. LXXIX. Synthesis of 1α, 25-dihydroxy-26, 26, 26, 27, 27, 27-hexafluorovitamin D3 | |
GB2077736A (en) | Vitamin d derivatives | |
CN1137899C (zh) | 17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物 | |
WO2008015696A2 (en) | Process for preparing ciclesonide | |
Dauben et al. | Synthesis of 6-fluorovitamin D3 | |
Laurent et al. | New biologically active pregnan-21-oic acid esters | |
Proudfoot et al. | Minor and trace sterols from marine invertebrates. 50. Stereostructure and synthesis of nicasterol, a novel cyclopropane-containing sponge sterol | |
EP0095894A2 (en) | 6 Alpha-methylprednisolone derivatives | |
CS266580B2 (en) | Method of androstane-17 beta-carboxyl acid's new esters production | |
OHSHIMA et al. | Synthesis of 1α-fluorovitamin D3 | |
Schänzer et al. | Synthesis of deuterated steroids for GC/MS quantification of endogenous steroids | |
Kurosawa et al. | Synthesis of diastereomers of 3α, 7α, 12α, 24-tetrahydroxy-and 3α, 7α, 24-trihydroxy-5β-cholestan-26-oic acids and their structures | |
Kasal | Epalons: 6-substituted derivatives of 7-norepiallopregnanolone | |
EP0875516A2 (en) | Process for the preparation of 16,17 acetals of pregnane derivatives with control of the epimeric distribution at the C-22 position | |
Marwah et al. | Steroidal allylic fluorination using diethylaminosulfur trifluoride: A convenient method for the synthesis of 3β-acetoxy-7α-and 7β-fluoroandrost-5-en-17-one | |
Swaminathan et al. | Inhibitors of sterol synthesis. Chemical synthesis and properties of 3 beta-hydroxy-25, 26, 26, 26, 27, 27, 27-heptafluoro-5 alpha-cholest-8 (14)-en-15-one and 25, 26, 26, 26, 27, 27, 27-heptafluorocholesterol and their effects on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured mammalian cells | |
Brash et al. | A comparison of t‐butyldimethylsilyl and trimethylsilyl ether derivatives for the characterization of urinary metabolites of prostaglandin F2α by gas chromatography mass spectrometry | |
Galli-Kienle et al. | Reduction of. DELTA. 24 of lanosterol in the biosynthesis of cholesterol by rat liver enzymes. II. Stereochemistry of addition of the C-25 proton | |
Pitt et al. | General synthesis of side-chain derivatives of cannabinoids | |
KURAMOTO et al. | Syntheses of 22-and 23-hydroxylated bile alcohols | |
Moreau et al. | Synthesis of 5. alpha.-cholesta-7, 24-dien-3. beta.-ol and cholesta-5, 7, 24-trien-3. beta.-ol | |
DD261364A5 (de) | Verfahren zur herstellung von ausgangsverbindungen fuer glucocorticosteroiden, die in der humanmedizin und veterinaermedizin angewendet werden kann | |
Ksebati et al. | 24ξ-Methyl-5α-cholestane-3β, 5, 6β. 22r. 24-pentol 6-acetate: New polyhydroxylated sterol from the soft coral asterospicularia randalli. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI PHARMACEUTICAL( GROUP ) CO., LTD. Free format text: FORMER OWNER: HUALIAN PHARMACEUTICAL CO., LTD., SHANGHAI Effective date: 20060310 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20060310 Address after: 200020 No. 200, Taicang Road, Shanghai Patentee after: Shanghai Medical (Group) Co.Ltd Address before: 200083 No. 370 West Bay Road, Shanghai Patentee before: Shanghai Hualian Pharmaceutical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI NEW HUALIAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI PHARMACEUTICAL (GROUP) CO., LTD. Effective date: 20110627 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200020 NO. 200, TAICANG ROAD, SHANGHAI TO: 201419 NO. 217, MINYUE ROAD, XINGHUO DEVELOPMENT ZONE, HAIWAN TOWN, FENGXIAN DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110627 Address after: 201419 No. 217 Minle Road, Spark Development Zone, Fengxian District Bay Town, Shanghai Patentee after: Shanghai New Hualian Pharmaceutical Co., Ltd. Address before: 200020 No. 200, Taicang Road, Shanghai Patentee before: Shanghai Pharmaceutical (Group) Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040211 Termination date: 20150316 |
|
EXPY | Termination of patent right or utility model |